“Phase 1 first-in-human intrathecal injection of gene therapy agent, AAV9/CLN-7 in Late Infantile Neuronal Ceroid Lipofuscinosis, Type CLN7”

Presented By: Saima Kayani, M.D.

Assistant Professor of Pediatric Neurology

UT Southwestern Medical Center